Cargando…
Efficacy of Two‐route Chemotherapy Using Intraperitoneal Neocarzinostatin and Its Antidote, Intravenous Tiopronin, for Peritoneally Disseminated Tumors in Mice
We assessed the efficacy of “two‐route chemotherapy (TRC)” using neocarzinostatin (NCS) given ip and its antidote, N‐(2‐mercaptopropionyl)‐glycine (tiopronin), given iv for peritoneally disseminated tumors in mice. Whether or not the single iv administration of tiopronin (800 mg/kg) at various times...
Autores principales: | Hasuda, Keitaro, Kobayashi, Hiroaki, Kuroiwa, Toshiro, Aoki, Ken, Taniguchi, Shun'ichiro, Baba, Tsuneo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917719/ https://www.ncbi.nlm.nih.gov/pubmed/2524462 http://dx.doi.org/10.1111/j.1349-7006.1989.tb02306.x |
Ejemplares similares
-
Differential Neutralizing Effect of Tiopronin on the Toxicity of Neocarzinostatin and SMANCS: A New Rescue Cancer Chemotherapy
por: Oda, Tatsuya, et al.
Publicado: (1989) -
Segmental NELL-1 Membranous Nephropathy Complicating Tiopronin Therapy
por: Santoriello, Dominick, et al.
Publicado: (2023) -
Effects of neocarzinostatin-chimeric Fab conjugates on the growth of human pancreatic carcinoma xenografts.
por: Otsuji, E., et al.
Publicado: (1996) -
Protective effects of tiopronin against oxidative stress in severely burned patients
por: Qin, Feng-Jun, et al.
Publicado: (2019) -
Assessment of health-related quality of life in patients with cystinuria on tiopronin therapy
por: Modersitzki, Frank, et al.
Publicado: (2019)